Cetera Investment Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Sell |
|
|||||
|
2025
Q1 | $2.07M | Buy |
|
|||||
|
2024
Q4 | $744K | Buy |
|
|||||
|
2024
Q3 | $524K | Sell |
|
|||||
|
2024
Q2 | $963K | Sell |
|
|||||
|
2024
Q1 | $1.4M | Buy |
|
|||||
|
2023
Q4 | $484K | Buy |
|
|||||
|
2023
Q3 | $427K | Buy |
|
|||||
|
2023
Q2 | $398K | Buy |
|
|||||
|
2023
Q1 | $343K | Buy |
|
|||||
|
2022
Q4 | $359K | Buy |
|
|||||
|
2022
Q3 | $263K | Sell |
|
|||||
|
2022
Q2 | $273K | Sell |
|
|||||
|
2022
Q1 | $459K | Sell |
|
|||||
|
2021
Q4 | $572K | Buy |
|
|||||
|
2021
Q3 | $471K | Buy |
|
|||||
|
2021
Q2 | $469K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $236K | Buy |
|